Krystian Ślusarz, Mikolaj Buchwald, Adrian Szczeszek, Szymon Kupinski, Anna Gramek-Jedwabna, Wojciech Andrzejewski, Juliusz Pukacki, Robert Pękal, Marek Ruchała, Rafał Czepczyński, Cezary Mazurek
{"title":"人工智能可能有助于基于[18F]FDG PET/CT放射组学特征预测甲状腺结节恶性。","authors":"Krystian Ślusarz, Mikolaj Buchwald, Adrian Szczeszek, Szymon Kupinski, Anna Gramek-Jedwabna, Wojciech Andrzejewski, Juliusz Pukacki, Robert Pękal, Marek Ruchała, Rafał Czepczyński, Cezary Mazurek","doi":"10.1186/s13550-025-01228-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The number of thyroid cancer diagnoses has been increasing for several decades, with a significant part of cases being detected incidentally (thyroid incidentaloma, TI) by imaging studies performed for reasons other than thyroid disease, including PET/CT with [<sup>18</sup>F]FDG. The chacteristics of the detected TI cannot be determined solely on the basis of conventional parameters used in everyday clinical practice, such as SUV<sub>max</sub>. In recent years, there has been a growing interest in radiomics, which is a quantitative method of analyzing radiological images based on the analysis of image texture. Textural analysis may be helpful, as it allows to characterize features invisible to the physician with the naked eye.</p><p><strong>Results: </strong>Of the 54 patients who presented focal [<sup>18</sup>F]FDG-avid TI and had subsequent fine needle aspiration biopsy, 4 patients were excluded from the analysis due to the unavailability of the final diagnostic information. Hence, in the final analysis, data from 50 patients were used (39 females and 11 males) with a mean age of 58.5 ± 11.26. Of these 50 patients, 11 (22.0%) [<sup>18</sup>F]FDG-avid nodules were diagnosed as malignant. The performance of the XGBoost model in assessing [<sup>18</sup>F]FDG-avid TI was similar (0.846 [confidence interval, CI, 95% 0.737-0.956]) to SUV<sub>max</sub> (0.797 [CI 95%: 0.622-0.973]; p = 0.60).</p><p><strong>Conclusions: </strong>With an AI-based algorithm using radiomics features it is possible to detect the malignancy of thyroid nodule. However, no statistically significant differences were observed between the AI and radiomics approach, and when using a conventional measure, i.e., SUV<sub>max</sub>.</p>","PeriodicalId":11611,"journal":{"name":"EJNMMI Research","volume":"15 1","pages":"39"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992293/pdf/","citationCount":"0","resultStr":"{\"title\":\"AI may help to predict thyroid nodule malignancy based on radiomics features from [<sup>18</sup>F]FDG PET/CT.\",\"authors\":\"Krystian Ślusarz, Mikolaj Buchwald, Adrian Szczeszek, Szymon Kupinski, Anna Gramek-Jedwabna, Wojciech Andrzejewski, Juliusz Pukacki, Robert Pękal, Marek Ruchała, Rafał Czepczyński, Cezary Mazurek\",\"doi\":\"10.1186/s13550-025-01228-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The number of thyroid cancer diagnoses has been increasing for several decades, with a significant part of cases being detected incidentally (thyroid incidentaloma, TI) by imaging studies performed for reasons other than thyroid disease, including PET/CT with [<sup>18</sup>F]FDG. The chacteristics of the detected TI cannot be determined solely on the basis of conventional parameters used in everyday clinical practice, such as SUV<sub>max</sub>. In recent years, there has been a growing interest in radiomics, which is a quantitative method of analyzing radiological images based on the analysis of image texture. Textural analysis may be helpful, as it allows to characterize features invisible to the physician with the naked eye.</p><p><strong>Results: </strong>Of the 54 patients who presented focal [<sup>18</sup>F]FDG-avid TI and had subsequent fine needle aspiration biopsy, 4 patients were excluded from the analysis due to the unavailability of the final diagnostic information. Hence, in the final analysis, data from 50 patients were used (39 females and 11 males) with a mean age of 58.5 ± 11.26. Of these 50 patients, 11 (22.0%) [<sup>18</sup>F]FDG-avid nodules were diagnosed as malignant. The performance of the XGBoost model in assessing [<sup>18</sup>F]FDG-avid TI was similar (0.846 [confidence interval, CI, 95% 0.737-0.956]) to SUV<sub>max</sub> (0.797 [CI 95%: 0.622-0.973]; p = 0.60).</p><p><strong>Conclusions: </strong>With an AI-based algorithm using radiomics features it is possible to detect the malignancy of thyroid nodule. However, no statistically significant differences were observed between the AI and radiomics approach, and when using a conventional measure, i.e., SUV<sub>max</sub>.</p>\",\"PeriodicalId\":11611,\"journal\":{\"name\":\"EJNMMI Research\",\"volume\":\"15 1\",\"pages\":\"39\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11992293/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13550-025-01228-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13550-025-01228-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT.
Background: The number of thyroid cancer diagnoses has been increasing for several decades, with a significant part of cases being detected incidentally (thyroid incidentaloma, TI) by imaging studies performed for reasons other than thyroid disease, including PET/CT with [18F]FDG. The chacteristics of the detected TI cannot be determined solely on the basis of conventional parameters used in everyday clinical practice, such as SUVmax. In recent years, there has been a growing interest in radiomics, which is a quantitative method of analyzing radiological images based on the analysis of image texture. Textural analysis may be helpful, as it allows to characterize features invisible to the physician with the naked eye.
Results: Of the 54 patients who presented focal [18F]FDG-avid TI and had subsequent fine needle aspiration biopsy, 4 patients were excluded from the analysis due to the unavailability of the final diagnostic information. Hence, in the final analysis, data from 50 patients were used (39 females and 11 males) with a mean age of 58.5 ± 11.26. Of these 50 patients, 11 (22.0%) [18F]FDG-avid nodules were diagnosed as malignant. The performance of the XGBoost model in assessing [18F]FDG-avid TI was similar (0.846 [confidence interval, CI, 95% 0.737-0.956]) to SUVmax (0.797 [CI 95%: 0.622-0.973]; p = 0.60).
Conclusions: With an AI-based algorithm using radiomics features it is possible to detect the malignancy of thyroid nodule. However, no statistically significant differences were observed between the AI and radiomics approach, and when using a conventional measure, i.e., SUVmax.
EJNMMI ResearchRADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-
CiteScore
5.90
自引率
3.10%
发文量
72
审稿时长
13 weeks
期刊介绍:
EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.